Challenges of primate embryonic stem cell research.

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Developmental Biology

Background:

• Embryonic stem (ES) cells offer potential for treating degenerative diseases like diabetes and Parkinson's.
• Human ES cell research faces ethical controversies and challenges in obtaining genetically normal comparative data.
• Existing human ES cell lines may harbor undetected genetic anomalies, including mitochondrial DNA defects.

Purpose of the Study:

• To advocate for robust research programs utilizing rhesus monkey ES cells.
• To establish normal primate ES cells as a 'gold standard' for comparative studies.
• To advance the understanding of normal stem cell biology and directed differentiation protocols.

Main Methods:

• Reviewing existing research on human and primate ES cells.
• Comparing ES cell lines derived from in vitro fertilization (IVF) and in vivo-generated embryos.
• Analyzing methods for detecting chromosomal and mitochondrial DNA anomalies in ES cells.

Main Results:

• Rhesus monkey ES cell lines derived from normal, in vivo-generated embryos can serve as a valuable comparative standard.
• Human ES cell research solely reliant on human cell lines may yield incomplete data.
• Gross chromosomal errors are detectable in ES cells, but mitochondrial defects may be overlooked.

Conclusions:

• Parallel research using rhesus monkey and human stem cells is essential for comprehensive understanding.
• This approach will accelerate the development of safe and effective stem cell therapies for human diseases.
• Utilizing normal primate ES cells as a benchmark is critical for advancing regenerative medicine.